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Abstract
The study of anticancer agents that act via stabilization of telomeric G-quadruplex DNA (G4DNA) is important because such
agents often inhibit telomerase activity. Several types of G4DNA binding ligands are known. In these studies, the target
structures often involve a single G4 DNA unit formed by short DNA telomeric sequences. However, the 39-terminal single-
stranded human telomeric DNA can form higher-order structures by clustering consecutive quadruplex units (dimers or n-
mers). Herein, we present new synthetic gemini (twin) bisbenzimidazole ligands, in which the oligo-oxyethylene spacers join
the two bisbenzimidazole units for the recognition of both monomeric and dimeric G4DNA, derived from d(T2AG3)4 and
d(T2AG3)8 human telomeric DNA, respectively. The spacer between the two bisbenzimidazoles in the geminis plays a
critical role in the G4DNA stability. We report here (i) synthesis of new effective gemini anticancer agents that are selectively
more toxic towards the cancer cells than the corresponding normal cells; (ii) formation and characterization of G4DNA
dimers in solution as well as computational construction of the dimeric G4DNA structures. The gemini ligands direct the
folding of the single-stranded DNA into an unusually stable parallel-stranded G4DNA when it was formed in presence of the
ligands in KCl solution and the gemini ligands show spacer length dependent potent telomerase inhibition properties.
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Introduction
The 39-end of the telomeric DNA plays a crucial role in
chromosome stability and in the protection from degradation,
fusion or recombination [1–3]. Few hundred nucleotides at the
terminal end of chromosomes, called telomere, remain single-
stranded and are folded into four stranded structures, called the G-
quadruplex DNA (G4DNA), a structure induced by Na
+ or K
+
ions or by some small organic ligands [4–8]. This structure is
refractory to telomerase, a ribonucleoprotein of about 170 kDa,
which is up-regulated in about 85% of human tumors and is
undetectable in most of the normal somatic cells [4,5].
Human telomeric DNA comprises the hexanucleotide 59-
TTAGGG- repeats and these repeats spontaneously fold into
two distinct but related hybrid-types, i.e., hybrid-1 (Figure 1)o r
hybrid-2 telomeric G-quadruplexes, depending on the flanking
sequences [4,5,9–11]. DNA sequence, e.g., d(T2AG3)4 and its
variants, e.g., d[AG3(TTAG3)3], d[G3(T2AG3)3], d[T2A(G3-
T2A)3G3T2] etc. form a single G-quadruplex loop or a monomer
of the G4DNA [9,11–16]. Recent studies show that a 48-mer
sequence d(T2AG3)8 and its 50-mer variant sequence
d(T2AG3)8TT form dimeric G4DNA structures containing two-
folded G-quadruplex units [17–19]. It has been proposed that the
multiple repeats of this sequence, i.e., d(T2AG3)n fold and stack,
end-to-end, to form compact-stacking structures containing several
G-quadruplex units [10,20,21]. RNA also forms G-quadruplex
structure. Recently, long RNA transcripts of human telomeric
repeats (TERRA), i.e., r(UUAG3)n have been predicted to form
multimeric G-quadruplexes, and the eight repeat sequence, i.e.,
r(UUAG3)8 forms a dimeric G-quadruplex [22].
Small molecule ligands that promote and stabilize G4DNA
structures are used as potential anticancer agents [4,5,23–25]. G-
quadruplex ligands developed so far have been confined for the
recognition of a single unit of G4DNA. Ligands in which two or
more G4DNA binding pharmacophore units are linked through a
suitable spacer may bind with two or more contiguous G-
quadruplex units. Some dimeric (gemini) G4DNA binding ligands
have been synthesized recently, but they were investigated with the
monomeric G4DNA [26–28]. To the best of our knowledge,
investigation related to the binding properties of a gemini ligand
with a dimeric G4DNA has never been reported.
Using a series of ligands based on 1, 3-phenylene-bis
(piperazinyl benzimidazole) previously we have shown the
stability, topological changes and induction (in absence of any
added cations) of G4DNA derived from the sequence d(T2G4)4,
telomeric repeat from tetrahymena thermophilia [29] and human
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synthesis of new gemini ligands in which appropriate bisbenzimi-
dazole monomers are linked via different oligoxyethylene spacers
(for synthesis and characterization of the ligands, please see the
Supporting Information, Text S1), and demonstrate their
interaction with G4DNAs formed by human telomeric repeats,
d(T2AG3)4 and d(T2AG3)8. We also show the ability of these
ligands to induce the formation of parallel G4DNA in K
+ solution.
Furthermore, the gemini ligands inhibit the telomerase activity
and also display selective cytotoxicity towards the cancer cells.
Results
Because of their significant cellular membrane permeability,
benzimidazoles are used in cytometry, in staining vertebrate
chromosomes, radioprotection, enzymatic inhibition and in the
stabilization of duplex, triplex and G4DNA [29–37]. Herein we
employed a monomeric ligand (M) [29] having central symmetrical
‘V’-shaped planar core and three of its gemini analogues (D1, D2
and D3) in which two monomeric units are joined via oligoox-
yethylene spacers of different lengths (Figure 1D). The angular
geometry of the ligand plays an important role in the G4DNA
stabilization [29,36,38,39]. Owing to their unusual hydrophilic,
lipophilic and biological properties of polyethylene glycol (PEG),
incorporation of oligo(ethylene glycol)s as spacer further increases
theusefulnessofsuchpharmacophores[40].Na
+andK
+ionsinduce
the G4DNA structures and also provide sufficient stability to the
G4DNA without any added ligand. Li
+ ions on the other hand,
induce the G4DNA formation, but they do little toward the G-
quadruplex stabilization [29,41]. The structure of the G4DNA
formed by four repeat sequence d(T2AG3)4 has been well
characterized in various solution conditions [42,43]. In Na
+
solution, it forms an intramolecular, anti-parallel basket type
G4DNAcontainingtwolateralloopsandonediagonalloop,similar
totheonereportedford[AG3(T2AG3)3](Figure1A)[42,44].InK
+
solution, it forms mainly a unimolecular structure, having anti-
parallel/parallel strands with one propeller and two lateral loops
(3+1 hybrid) along with a small percentage of other structures [42–
44]. For the sequence d(T2AG3)8, a dimeric hybrid-12 quadruplex
structure (formed by a hybrid-1 quadruplex at the 59-end and a
hybrid-2 quadruplex at the 39-end) and a propeller G4DNA have
been suggested to be the most stable structure in K
+ stabilized
conditions based on computational studies [19]. This sequence is
predicted to form a dimeric structure in Na
+ solution on the basis of
electrophoresis studies [18], but no other studies (including
computational) for the system in Na
+ solution have been reported.
Four buffer systems were used in the present study. One of them
has (Na
+ + LiCl) (10 mM sodium cacodylate having 100 mM LiCl
and 0.1 mM EDTA, pH 7.4) and the other three have either of
LiCl or NaCl or KCl (100 mM of either LiCl or NaCl or KCl,
0.1 mM EDTA, and 10 mM Tris-HCl buffer, pH 7.4) respec-
tively. Thermal annealing conditions were used to form the
G4DNAs from the oligodeoxynucleotides (ODNs) d(T2AG3)4 and
d(T2AG3)8 (abbreviated as Hum24 and Hum48 respectively, see
Materials and Methods for further details).
Circular Dichroism Spectral Titrations
Circular dichroism (CD) spectra of the G4DNA formed by
Hum24 in NaCl and KCl were similar to the ones reported earlier
Figure 1. Topology of the G4DNA and the ligands used in the study. (A-C) Folding topology of the monomeric intramolecular G4DNAs as
elucidated from NMR or X-ray crystallography: A) basket-type intramolecular G4DNA in Na
+ solution (NMR) B) hybrid-1 intramolecular G4DNA in K
+
solution (NMR) and C) propeller-type parallel-stranded intramolecular G4DNA in presence of K
+ in the crystalline state (X-ray crystal structure). (D)
Chemical structures of the ligands used in the present study.
doi:10.1371/journal.pone.0039467.g001
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+ solution it showed two positive
peaks of approximately equal intensity (at 295 and 247 nm) with
two valleys (at 265 and 240 nm). Incidentally, both of these spectra
had a valley near 265 nm, and not a negative peak as reported
[43]. In Li
+ solution (100 mM Li
+ and 10 mM Na
+) it showed two
positive peaks (a small peak at 295 nm and large peak at 247 nm)
with a hump near 270 nm and two valleys (near 280 and 240 nm).
CD spectrum of d(T2AG3)4 recorded in K
+ solution showed a
positive peak near 285 nm, shoulders near 268 and 250 nm, and a
negative peak around 240 nm. Such a spectrum is consistent with
the ones reported for similar sequences in K
+ solution [42,43]. The
spectra appeared similar to those observed for other variants, e.g.,
d[A3G3(T2AG3)3A2] and d[(T2AG3)3A2]i nK
+ solution but were
different from that observed for d[A3(T2AG3)3] [9,11–15]. CD
spectra for the G4DNA formed with ODN Hum48 in all the salt
solutions (Na
+,K
+ or Li
+) were again similar to those observed
with the Hum24 G4DNA, but the intensity of the peaks were
higher (Figure 2B). Spectra in K
+ solution are again consistent
with the reported ones [13,18,43].
Next we prepared the G4DNA from Hum24 and Hum48
sequences in 100 mM LiCl solution (10 mM Tris.HCl, pH 7.4
having 100 mM LiCl and 0.1 mM EDTA) [44]. CD spectra of
G4DNA recorded in Li
+ solution showed a hump near 277 nm
and a peak near 257 nm (Figure S1). This CD spectral profile is
different from that recorded in (Na
+ + Li
+) solution, indicating that
topology of G4DNA is different in both the cases.
We also performed the CD titrations of the pre-formed Hum24
G4DNA with gemini ligand D3 in (Na
+ + LiCl) buffer (10 mM
sodium cacodylate having 100 mM LiCl, pH 7.4) and KCl buffer.
There was no structural change in these conditions (Figure S2).
But the peak intensities changed and a small induced CD (ICD)
signal also appeared near 330 nm showing an interaction of the
ligands with the G4DNA tetrads and its grooves. Monomeric
ligand M also furnished similar results (not shown).
The CD titrations of the pre-formed Hum48 G4DNA were
separately carried out with the monomeric ligand M and gemini
ligand D3 in (Na
+ + LiCl) buffer (10 mM sodium cacodylate
having 100 mM LiCl and 0.1 mM EDTA). Interestingly, the
intensity of the 295 nm peak increased in both the cases with little
effect on the 247 nm peak. In the case of Hum48-M complexation,
three peaks of approximately equal intensity (245, 270 and
295 nm) were observed due to appropriate ligand-DNA interac-
tions (Figure S3). But in the case of Hum48-D3 complex, the
intensity of the 290 nm peak was much higher and the spectrum
was more like that of a K
+-ion stabilized Hum48 G4DNA (Figure
S3). A significant ICD signal near 327 nm also appeared in both
Figure 2. CD spectra of the G4DNA without ligands and CD titrations in KCl solution. Circular dichroic (CD) spectral profiles of G4DNA
formed using the Hum24 (Panel A) and the Hum48 (Panel B), 4 mM DNA in each case, in presence of the indicated monovalent cations (100 mM).
(Panels C and D) CD spectral titrations of the pre-formed G4DNA (4 mM strand concn.) formed using the Hum48 in KCl buffer (10 mM Tris, pH 7.4
having 100 mM KCl) in presence of M (Panel C) and D3 (Panel D) at ligand: DNA ratio (r)=10, 20, 30 (for M) and r=5, 10, 15, 20 (for D3). Arrows
indicate the direction of increments observed in the CD intensity.
doi:10.1371/journal.pone.0039467.g002
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Hum48 G4DNA. The ICD signal most likely appears due to an
interaction of the achiral ligand with the chiral grooves of the
G4DNA. The side chains of the ligands should also have their role
in the G4DNA groove binding [29].
CD titrations of the pre-formed G4DNA formed in 100 mM
LiCl solution (10 mM Tris-HCl, pH 7.4 having 100 mM LiCl and
0.1 mM EDTA) with the ligands M and D3 did not show any
topology change. However, a strong ICD signal appeared near
325 nm upon ligand-G4DNA interaction (Figure S1). The
interactions of ligands with DNA were quite strong in this case
and the CD spectra became distorted after interaction with 12
equiv. of M.
The solution structure of K
+-stabilized G4DNA has significant
biological relevance [42,43]. CD titrations of the pre-formed
Hum48 G4DNA in K
+ solution with either M or D3 showed that
the 285 nm peak became stronger in both the cases and the
negative peak at 240 nm lifted upwards progressively (Figure 2C,
2D). An ICD signal near 328 nm also appeared in both the cases.
No topology change was apparent in the pre-formed G4DNA after
interacting with either of the ligands. Similarly, there was no
change in the topology of the pre-formed Hum48 G-quadruplex
DNA in Na
+ solution upon interaction with the ligands.
But significant structural changes occurred in the CD spectral
profile of Hum24 G4DNA formed (first heated to 95uC for 5 min
and then cooled slowly to room temp.) in presence of either the
monomeric or the gemini ligands in 100 mM K
+ solution.
Interestingly, at [ligand]:[DNA] ratio (‘r’) of ,10, all the three
peaks merged to give a peak near 265 to 270 nm and a shoulder
near 295 nm (Figure 3A). The 270 nm peak is broader in the
case of D3. This profile is similar to the CD spectral profile of the
parallel G4DNAs formed by human and many non-human
telomere DNA sequences, although a shallow was there at 237 nm
and no negative peak was seen [29,45–48].
Hum48 sequence also produced similar CD spectra (as with the
Hum24 sequence) when the corresponding G4DNA was formed
from it in presence of either monomeric or gemini ligands in
100 mM K
+ solution. Each of the ligands M, D2 and D3 gave rise
to a strong sharp peak near 265 nm, while D1 furnished a broad
peak near 275 nm (Figure 3B to 3E). The peaks were sharper in
case of M, D2 and D3. These spectral features are again
consistent with that of a parallel G4DNA [29,45–48].
Thermal Denaturation Studies
In the thermal denaturation experiments, monomer M and its
gemini counterparts showed characteristic melting curves at
295 nm and evidence of significant stabilization of the pre-formed
Hum24 and Hum48 G4DNAs in 10 mM Na
+ +100 mM LiCl
solution at ‘r’ of 10 (r=20 in case of M)( Table 1; Figure S4).
We have chosen (sodium cacodylate + LiCl solution) because Li
+
helps in the formation of G4DNA but it has practically no effect
on the stability of G4DNA. Then we may have a better idea about
the stabilization provided by any G4DNA stabilizing ligand under
these conditions [29,41]. Substitution of electron-donating alkoxy
groups on the phenyl ring of benzimidazole is known to increase
its DNA binding affinity further [29,35]. Stabilization was
considerably higher in the case of the gemini ligands. Gemini
ligand D3 induced higher stabilization of the Hum48 G4DNA
than D2 and the stabilization was even higher when the G4DNA
was formed in presence of D3 (Table 1). We also performed the
melting experiments in 100 mM LiCl solution (10 mM Tris-HCl,
pH 7.4 having 100 mM LiCl and 0.1 mM EDTA) [44]. Ligands
provided stabilizations ranging from 6uCt o1 0 uC to the G4DNA
(Table S1), indicating the poor interaction with the ligands under
these conditions.
Next we performed the thermal denaturation experiments in
100 mM NaCl solution. The results were similar to those in the
case of (Na
+ + LiCl) solution (Table 1; Figure S5). Two gemini
ligands provided significantly higher stabilization to G4DNA.
Likewise the extent of stabilization provided by each ligand to the
pre-formed G4DNA was again similar in KCl solution (Table 2;
Figure S6). Gemini ligands consistently afforded higher stabili-
zation of the G4DNA and the effect of the spacer length was also
significant. Thus D2 with a shorter spacer provided somewhat
lower stabilization to the Hum24 G4DNA than D3 which
possesses a longer spacer.
Importantly, the monomer M and the gemini ligands provided
much higher stabilization to the complex when the G4DNA was
formed in the presence of respective compound in 100 mM KCl
solution (first heated to 95uC for 5 min and then cooled slowly to
room temp.). Gemini ligands formed more stable complexes and
the stability of the parallel G4DNA formed in presence of these
ligands, increased with the spacer length in both the cases (Hum24
and Hum48, Table 2; Figure S7).
During cooling, the Hum48 DNA did not show any evidence of
any specific structure formation (Figure S7C). Cooling of the
mixture of Hum48 with D3 however, resulted in a G-quadruplex
formation. The cooling curve was not superimposable with the
heating curve. Ligand D3 binds and stabilizes G4DNA driving the
ssDNA « G4DNA equilibrium toward G4DNA and therefore
this might have accelerated the folding process [49].
Absorption and Fluorescence Titrations
Gemini ligands showed high G4DNA vs. duplex DNA
selectivity. Absorption titration (Figure S8) results show that the
binding affinity of the gemini ligands towards G4DNA increases
with the spacer length (Table S2, Figure S9). Importantly, the
gemini ligand D3, with the longest spacer between the
pharmacophore units, has the highest affinity for the G4DNA
(Hum48). D3 also showed a large difference in the affinity for
G4DNA over the duplex DNA.
Gemini ligands having oligooxyethylene spacers are capable of
forming non-cyclic crown ether-like conformations in presence of
suitable metal ions [28,50]. Thus the gemini ligands may form
‘hairpin’ type complexes having reduced fluorescence emission
and absorbance (Figure S10)i nK
+ solution. Interestingly, after
complexation with metal ion, their activities in terms of their
interaction with G4DNA or duplex DNA do not change [28,50].
Solutions of gemini ligands (D1, D2 and D3) have lower
fluorescence emission in 100 mM K
+ solution. After addition of
the pre-formed Hum48 G4DNA, the fluorescence intensity started
increasing, indicating the binding of ligands with the G4DNA
(Figure S10). Increment in the fluorescence intensity also
depended on the spacer length and D3 showed the highest
affinity with the G4DNA.
Telomerase inhibition studies. The inhibition of telome-
rase activity is considered as an important indicator for the
anticancer activity of a drug. This drug interacts with telomeric G-
rich overhang and stabilized G-quadruplex DNA. So this type of
molecules acts through dual role as inhibitor of telomere
uncapping and telomerase inhibitors [51,52]. Monomer M and
gemini ligands D1-D3 were evaluated for their ability to inhibit
human telomerase using conventional two step telomerase repeat
amplification protocol (TRAP) assay [23,38] and modified three
step TRAP–LIG protocol assay [53]. On the basis of this assay the
ligand which stabilized the G4DNA structure shows telomerase
inhibition activity. In modified TRAP–LIG assay the extra step is
Spacer Length Effect on Telomerase Inhibitors
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PCR step of the assay (see Materials and Methods). Sometimes the
ligand has its own inhibitory activity on Taq polymerase and
therefore it may affect the PCR amplification. Each ligand was
tested at increasing concentrations (in the range of 2.5 mMt o
60 mM) against telomerase extract from A549 (human lung
carcinoma cell line) cells. As shown (Figure S11) by the
conventional TRAP assay method, with increasing concentration
of ligands a decrease in intensity of the ladders was observed. But
in case of TRAP-LIG assay protocol the potency of ligand activity
appears to have decreased (Figure 4). It requires higher
concentration of the ligands to inhibit the same amount of
telomerase protein. In TRAP-LIG assay ligand M inhibits the
telomerase activity at 60 mM( Figure 4A). Among the gemini
ligands, D1 inhibits at 30 mM while D2 and D3 at ,15 mM. The
IC50 values for the telomerase inhibition by the TRAP-LIG
protocol have been also estimated and are shown in Table 3 and
in Figure S12. Importantly, the gemini ligand D3 displays
significantly lower IC50 values than the other two gemini ligands.
Cancer Cell-specific Toxicity
Next we examined the effects of each ligand on three different
cancer cell lines, i.e., HeLa, A549 and NIH3T3. First we
performed short-term cell viability study for 6 h. Eventually a
48 h cytotoxicity assay (MTT assay) was performed with each
ligand (Figure S13). Each ligand exerted an inhibitory effect and
evidently each gemini ligand was more cytotoxic towards the
cancer cells than that of the monomeric ligand, M, as reflected
from the respective IC50 values (Table S3).
To evaluate the long-term effects of each ligand on the growth
of cancer cells, sub-cytotoxic concentrations (4 mM) of ligands
were employed to lessen acute cytotoxicity and other off-target
events. Generally, each ligand exerted significant inhibitory effect
Figure 3. Evidence of change in Topology of the G4DNA using CD spectroscopy. (Panel A) CD spectral profiles of free G4DNA derived from
the Hum24 DNA (4 mM, black) and G4DNA formed in presence of the indicated ligand in KCl solution. (Panels B to E) CD spectral profiles of free
G4DNA derived from the Hum48 DNA (black, 4 mM in the case of ‘B’ while 2 mM in other cases) and G4DNA formed in presence of the indicated ligand.
Solution (10 mM Tris, pH 7.4 having 100 mM KCl), with or without the ligands, was first heated to 100uC for 5 min and then cooled slowly to room
temperature to form the G4DNA in each case.
doi:10.1371/journal.pone.0039467.g003
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the inhibitory effect of ligands towards cancer cells over normal
cells, we performed MTT assay on HEK293 normal cells and
HEK293T cancer cells. Each ligand was found to be significantly
more toxic towards the cancer cells than the normal cells at all the
concentrations tested (Figure 5). All the ligands are effective at
much higher IC50 values (48 h treatment) for the HEK293 cells
(.150 mM, Table S3) than that for the transformed HEK293T
cells (,30 mM). Among all the ligands, D3 showed the lowest IC50
value (15 mM) of toxic response toward the HEK293T cancer
cells. Further we have tested the cancer cell selectivity study with
very well-known G-quadruplex binding molecule H2TMPyP4.
This molecule was found to be non-selective for the normal
embryo kidney HEK293 cells against cancerous HEK293T cells.
Further the IC50 values of this compound for each cell line tested
were found to be significantly higher than 100 mM( Figure S15).
Molecular Modeling
To gain more insights into the nature of binding of the ligands
with the telomeric G4DNA, an approach that combined
molecular docking and MD simulations, was performed. Higher
order arrangements with several G-quadruplex repeats feasible
in vivo are allowed as a consequence of the length of the telomeric
DNA. However, no high resolution structural data are still
available for these longer sequences and such sequences may
indeed be difficult to study by the usual NMR or crystallographic
methods. The higher order structures and the stability of the full
length overhang must be known in order to fully understand the
nature of interactions of DNA with the telomerase and other
telomere-binding proteins. This structural information on the
higher order human telomeric G4DNA formed under physiolog-
ically relevant conditions is further necessary for the structure
based rational drug design.
Based on a previous report [19] we have used the molecular
modeling methods to build a model of G4DNA dimer from the
extended human telomeric DNA sequence. Two high resolution
NMR structures for the human telomeric sequence in K
+ solution
are available, and these are known as hybrid-1 and hybrid-2
G4DNAs, respectively. These are made up of 26-mer DNA, and
were used to build the dimeric G4DNAs [10]. These two
structures are highly dominant in a native, non-modified human
telomeric DNA sequence in K
+ solution. Both structures contain
three G-tetrads linked mixed parallel/antiparallel G-strands. They
Table 1. Melting temperatures
a of Hum24 and Hum48
G4DNAs formed in (Na + LiCl)
b and NaCl
c solutions and
G4DNA-ligand complexes ([ligand]:[DNA] ratio ‘r’=20 for M
and 10 for the gemini ligands respectively).
Entry
ODN/ODN-
ligand LiCl solution NaCl solution
Tm 6C DTm 6C
d Tm 6C DTm 6C
d
1. Hum24 37 0 41 –
2. Hum24 + M 45 8 47 6
3. Hum24 + D1
e –– – –
4. Hum24 + D2 46 9 49 8
5. Hum24 + D3 49 12 52 11
6. Hum48 38 – 42 –
7. Hum48 + M 47 9 49 7
8. Hum48 + D1
e –– – –
9. Hum48 + D2 52 14 52 10
10. Hum48 + D3 55 17 55 13
11. Hum48 + D3
f 57 19 56 14
aChanges in the circular dichroism spectral peak at 295 nm monitored as a
function of temperature using 2 mM strand ODN concentration.
b(Na + LiCl
solution) = (10 mM sodium cacodylate pH 7.4 having 100 mM LiCl and 0.1 mM
EDTA).
cNaCl solution = (10 mM Tris-HCl, pH 7.4 having 100 mM NaCl and
0.1 mM EDTA).
dDTm values were obtained from the difference in the melting
temperatures of the ligand bound and uncomplexed G4DNA.
eNo significant
increment in Tm.
fFor entry 11, the G4DNA was formed in LiCl buffer (first
heated to 95uC for 5 min and then cooled slowly). The results are average of
two experiments and are within 60.5uC of each other.
doi:10.1371/journal.pone.0039467.t001
Table 2. Melting temperatures (Tm)
a of Hum24 and Hum48 G4DNA, ligand bound to pre-formed G4DNA and complexes produced
when G4DNA was formed in presence of the indicated ligand at [ligand]:[DNA] ratio ‘r’=20 for the monomeric and ‘r’=10 for the
gemini ligands in 100 mM KCl solution.
Entry ODN/ODN-ligand Pre-formed G4DNA G4DNA formed in presence of the ligand
Tm 6C DTm 6C
b Tm 6C DTm 6C
b
1. Hum24 46 0 46 –
2. Hum24 + M 52 5 55 9
3. Hum24 + D1 62 16 70 24
4. Hum24 + D2 58 12 79 33
5. Hum24 + D3 68 22 84 38
6. Hum48 51 0 51 –
7. Hum48 + M 60 9 65 14
8. Hum48 + D1 67 16 79 28
9. Hum48 + D2 69 18 87 34
10. Hum48+ D3 72 21 89 38
aChanges in the circular dichroism spectral peak (at 295 nm for the G4DNA and the pre-formed G4DNA-ligand complex; at 266 nm for the G4DNA-ligand complex
formed in presence of ligand) monitored as a function of temperature using 2 mM strand ODN concentration.
bDTm values were obtained from the difference in the
melting temperatures of the ligand bound and uncomplexed G4DNA. For the G4DNA-ligand complexes when G4DNA was formed in presence of the ligand, the
solution was first heated to 95uC for 5 min and then cooled slowly. The results are average of two experiments and are within 60.5uC of each other.
doi:10.1371/journal.pone.0039467.t002
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arrangements, and capping structures. Hybrid-1 structure has
sequential side-lateral-lateral loops with the first TTA loop
adopting the double chain-reversal conformation. The hybrid-2
structure has lateral-lateral-side loops with the last TTA loop
adopting the double chain-reversal conformation. Both hybrid
structures contain three parallel G-strands and one anti-parallel G-
strand, five syn guanine and asymmetric G-arrangement. The first
G-tetrad (from the 59-end) has a reversed G-arrangement from the
other two G-tetrads. For the hybrid-1 structure, the first G-tetrad
is (syn: syn: anti: syn) and the bottom two are (anti: anti: syn: anti),
whereas for the hybrid-2 structure, the first G-tetrad is (syn: anti:
syn: syn) and the bottom two are (anti: syn: anti: anti)( Figure S16).
Using these two monomeric motifs as building blocks, we built a
dimeric model of G4DNA, named hybrid-12, which was formed
by putting the hybrid-1structure at 59-end and the hybrid-2
structure at the 39-end. We refined the initial structures using
molecular dynamics simulations. After an equilibration period of
250 ps, the model was subjected to an unrestrained molecular
dynamics trajectory of 8 ns duration (Figure S17).
After generating the stable dimeric G4DNA structure, molec-
ular docking studies were first carried out to predict the possible
interaction sites between the dimeric ligands and the G4DNA. We
used a 1:1 stoichiometry for the docking of the dimeric ligands
with the dimeric G4DNA by assuming that one bisbenzimidazole
unit of a dimeric ligand stack on one G4-plane of the first
quadruplex unit of the dimeric G4DNA while the second
bisbenzimidazole unit stacks on the G4-plane of the other
quadruplex unit of the same dimeric G4DNA. From the docking
results it is apparent that due to the steric hindrance on the top of
the G-tetrads by the AAA and TT overhangs, the flexible ligands
could be readily accommodated in the groove regions of the
dimeric hybrid structure. On the basis of the docking results, the
lowest final docked energy ligand-G4DNA complexes were chosen
and then MD simulations (8 ns) were performed separately on the
two complexes formed by dimeric G4DNA with the ligands D2
and D3. All the models were quite stable during the dynamics runs
(Figure 6A; RMSD values are given in Figure S18).
Discussion
The ligands used in this study possess a planar ‘V’-shaped
bisbenzimidazole unit as the core, the dimension of which matches
closely with those of the G-tetrads derived from human telomeric
repeats. Furthermore, one such bisbenzimidazole unit covers 3
bases of the G-tetrad and is able to provide high stabilization of the
G4DNA [29,38]. As per the CD spectral titrations upon
interaction with each ligand, no structural change in the pre-
formed Hum24 G4DNA in (Na
+ + Li
+) solution (10 mM Na
+ and
Figure 4. Telomerase inhibitory properties of ligands by TRAP-LIG assay. TRAP-LIG assay was performed using indicated concentrations
over each lane with M and D1 (A); D2 and D3 (B). A positive control was run with telomerase, but with no ligand. A negative control was run without
either telomerase or ligand. Positive and negative control lanes are indicated by + and – labels, respectively. Other lanes contain TRAP reaction
mixtures mixed with the indicated concentrations (mM) of each ligand.
doi:10.1371/journal.pone.0039467.g004
Table 3. IC50 values against Telomerase found for the
different lgands by TTAP-LIG assay
a.
Entry Ligand IC50 (mM)
1. M 55.4
2. D1 38.6
3. D2 32.2
4 D3 5.9
aThe results are average of three experiments and are within 61% of each
other.
doi:10.1371/journal.pone.0039467.t003
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+, SI) was observed. But there were clear changes in
the CD spectra of (Na
+ + Li
+) stabilized Hum48 G4DNA after
complexation with the monomeric ligand M. The CD spectra of
the complex resembled to that of the CD spectra of the K
+
stabilized d[AG3(T2AG3)3] quadruplex [9–11,42,43]. The changes
were more prominent in the case of Hum48-D3 titrations where
the CD spectra were similar to that of the K
+-stabilized Hum48
G4DNA (Figure S3), indicating stronger interaction between the
ligand and G4DNA. This was further corroborated from the
observation of a strong ICD signal in each case and from the
results of the thermal denaturation experiments.
As K
+ ion provides higher stabilization to the G4DNA, there
was no change in the topology of both pre-formed G4DNAs
(Hum24 and Hum48) after interaction with the monomeric and the
gemini ligands. However, the ICD signal observed in all the cases,
indicate significant interactions of the ligand with the chiral
grooves of the G4DNA after satisfying the G-tetrad stabilization.
‘V’-shaped ligands based on 1, 3-phenylene-bis (piperazinyl
benzimidazole) have already been shown to change the topology
of hybrid G4DNA derived from the 24-mer Tetrahymena sequence
[29,38] Similarly, electrophoretic data of the G4DNA derived
from the 21-mer human telomeric repeat d[G3(T2AG3)3]
complexed either with M or D1 indicate the formation of parallel
G4DNA conformation, when it was formed in presence of the
ligands [30]. In the present case, the CD titration data reveal that
the ligands direct the folding of ‘unstructured’ single-stranded
DNA (Hum24 and Hum48) into a parallel- stranded G4DNA when
it is formed in presence of a ligand in 100 mM K
+ solution. This
phenomenon was also observed for the 21-mer DNA
d[G3(T2AG3)3] in presence of the polyethylene glycol (PEG) in
K
+ solution, where PEG mimics cellular molecular crowding
conditions [14]. Telomeric sequence d[AG3(T2AG3)3] is known to
form parallel G-quadruplex crystals from K
+ solution [13] and
monomeric ligand M is able to cover the G-tetrad of this G4DNA
[29]. M also forms stable, parallel G4DNA with the sequence
d(T2G4)4 in absence of any added cation [29]. In other words the
pharmacophore unit of M has high affinity towards G4DNA. So a
high concentration of M in the vicinity of DNA in K
+ solution
should be responsible for the parallel folding of DNA. In case of
the gemini ligands, the oligooxyethylene spacer also has a role in
the G4DNA folding process. There was a sharp intense peak near
266 nm when the Hum24 G4DNA was formed in presence of M.
However, there was a broader peak near 270 nm in presence of
either D2 or D3, having the same core unit as M (Figure 3). M
binds with one G-tetrad at a given time. On the other hand the
gemini ligands bind with two G-tetrads of the same G4DNA
(preferably through end-stacking), or with the two G-tetrads from
two different G4DNAs [23]. Appearances of broader peaks near
270 nm in presence of D2 or D3-Hum24 complexes possibly
originate due to this competition in the binding modes. Again a
sharper and more intense peak near 269 nm was observed in the
case of Hum48-M complex when the G4DNA was formed in
presence of the ligand in K
+ solution (Figure 3). However, in
presence of the gemini ligands, different results were seen. Smaller
and broader peaks near 267 nm were seen in case of the Hum48-
D1 complex. It could be due to shorter spacer length in D1 (a
tetraethylene glycol spacer, 11 atom-long), which may not provide
sufficient length necessary between the two bisbenzimidazole units
to stack either on each of the two terminal G-tetrads from the
same G4DNA unit or from two different G4DNA units of the
same Hum48 sequence. Ligand D2 however, afforded sharper
peaks than D1 because of the presence of a longer spacer (14
atom-long), while D3, having 17 atom-long spacer afforded the
most intense peaks in their CD spectra (Figure 3D). These results
indicate that the spacer length of the gemini ligands assumes
critical role in the formation of parallel Hum48 G4DNA.
D1 did not provide any significant stabilization to the pre-
formed G4DNA (Hum24 and Hum48) in (Na
+ + Li
+) (100 mM Li
+
+10 mM Na
+) and 100 mM Na
+ solutions (Table 1). This may be
due to the shorter spacer in D1, which forms a pseudocyclic
structure in presence of Na
+ ions [50]. Other two gemini ligands
D2 and D3 provided 11uCt o1 7 uC stabilization in both the cases
showing the role of the spacer (Table 1). Interestingly the
stabilization was higher when the G4DNA was formed in presence
of D3 in either case, indicating a stronger binding of the ligand
with the G-tetrad. Gemini ligands provided higher stabilization, to
Hum24 and Hum48 G4DNAs in 100 mM K
+ solution, increasing
with their spacer length, than M, although D2 provided a slightly
lower stabilization of the Hum24 G4DNA (Table 2). The effect of
the spacer length was more apparent when the G4DNAs (Hum24
and Hum48) were formed in presence of ligands in 100 mM K
+
solution.
Figure 5. Selective toxicity of ligands toward cancer cells. Effect of the ligands on the cell viability after 48 h exposure of HEK293 (normal) and
HEK293T (cancerous) cells with each ligand at different concentrations as measured by MTT (methyl thiazolyl tetrazolium) assay. Each experiment was
repeated six times.
doi:10.1371/journal.pone.0039467.g005
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into pseudocyclic structures due to the presence of oligooxyethy-
lene spacers and their emission spectra have lower intensities
[28,50]. This pseudocyclic structure could be partly or fully
opened in the presence of G4DNA. Hence, the changes in the
fluorescence intensity would be even greater when interactions
occur with such DNA structures [28]. In other words, DNA
binding properties of the gemini ligands complexed with metal
ions are retained. The gemini ligands may also be protected
efficiently by DNA by the exclusion of solvent or the exclusion of
oxygen within the solvent. In our case, gemini ligands possess
sufficient, spacer length-dependent affinity (D3. D2. D1), for
G4DNA in presence of K
+ or Na
+. In case of D1, having the
shortest spacer, which form pseudocyclic complex with Na
+ ions,
the complex may not be opening because the shorter spacer could
not afford the length necessary for the two bisbenzimidazole units
of D1 to bind with different G4-planes of the Hum24 G4DNA or
the different quadruplex units of the Hum48 G4DNA.
The results of the TRAP-LIG assay again demonstrate the role
of the spacer length on the inhibition of telomerase activity by the
gemini ligands. The ligand D3 having 17 atom long spacer gave
the highest telomerase inhibition (Figure 4). Short and long term
cell survival assays further indicated the potency of the gemini
ligands with general spacer length effect. Moreover, the ligands
were found to be selectively detrimental to cancer cells than the
corresponding normal cells (Figure 5).
Molecular modelling studies suggest that due to the steric
crowding of the G-tetrads by overhanging of AAA and TT, both
the bisbenzimidazole units of the 14 atom spacer based ligand D2
accommodate itself in the groove of the G-quadruplex created by
the TTA lateral loops (Figure 6A), and the spacer adheres to the
surface of the TTA loops. On the other hand D3 with more
flexible and longer spacer showed two modes of binding, where
one of its bisbenzimidazole scaffold stacks on the 59-surface of the
G-quartet plane while the other bisbenzimidazole binds to the
groove of the second G4 DNA unit and the spacer interacts with
the surface of the loop (Figure 6B).
In summary we have developed four bisbenzimidazole based
ligands (one monomeric and three gemini) and compared their
propensity toward interaction with certain human telomeric
sequences possessing multiple G4DNA units. Though each ligand
provided considerable stabilization to G4DNA, gemini ligands
exhibited significantly higher affinity towards the G4DNAs, which
increased with the length of the oligooxyethylene spacer between
the two bisbenzimidazole units. The ligands directed the folding of
the telomeric DNA into an unusually stable parallel-stranded
structure when G4DNA was formed along with the ligand in K
+
solution. We propose a plausible model for the parallel-stranded
dimeric G4DNA (Figure 6D).
Gemini ligands inhibited the telomerase activity in vitro, and also
exhibited potent and selective cytotoxicity against cancer cell lines
as a function of their spacer lengths (Figure S19). These ligands
might be more useful in vivo because of the existence of multimeric
G4DNAs in the human genome [54,55]. In the present study, we
further show that gemini ligands have significantly higher
selectivity for G4DNA over duplex DNA and the selectivity
increases with the increase in the spacer length. Hence the
interference caused by their interaction with the duplex DNA in
vivo would likely to be minimal. In this regard, the dimeric (and/or
multimeric) ligands, linked via suitable spacers of appropriate
length may serve as more potent anticancer agents by targeting
telomeric multimeric G4DNA.
Materials and Methods
Materials
All materials and reagents were purchased from the best known
commercial sources. All cell lines used in this work were procured
from ATCC (USA) as described [56].
Synthesis
Monomeric compound M has been synthesized as reported
previously [29]. Dimeric compound (D3) has been synthesized as
described in the supporting information.
Oligonucleotides
HPLC purified oligodeoxyribonucleotides (ODN) d(T2AG3)4
and d(T2AG3)8 (abbreviated as Hum24 and Hum48 respectively)
were purchased from Sigma, Genosys, Bangalore. The purity of
each ODN was confirmed using high resolution sequencing gel.
The concentration of each ODN was determined from the
absorbance measurements at 260 nm based on their molar
extinction coefficients (e260) 244600 and 487600 respectively for
d(T2AG3)4 and d(T2AG3)8.
G4DNA Formation
Single-stranded ODNs Hum24 and Hum48 were dissolved in
required buffer at the indicated concentrations. The solution was
first heated to 95uC for 5 min, and then cooled slowly to room
temperature over a period of 24 h.
Circular Dichroism Spectroscopy, Fluorescence
Spectroscopy, UV-vis Absorption Titration Experiments
and Telomerase Repeat Amplification Protocol
(Conventional TRAP Assay)
These studies were performed following the procedure as
reported earlier [29,38].
Tm Studies
Tm measurements were performed on a Jasco J - 810 CD
spectropolarimeter in a quartz cell of 10 mm path length equipped
with a thermal programmer. CD change was monitored at
295 nm (for G-quadruplex without drugs) and ligand-G4 ligand
complex in either (Na + LiCl solution) (10 mM sodium cacodylate
pH 7.4 buffer having 100 mM LiCl and 0.1 mM EDTA) or NaCl
or KCl solution = (10 mM Tris-HCl, pH 7.4 buffer having
100 mM NaCl or KCl and 0.1 mM EDTA. CD spectral changes
were also observed at 266 nm for the drug/DNA complex when
G-quadruplex has formed in presence of ligands at KCl buffer.
The temperature was raised from 20 or 25 to 95uC at the rate of
1.0uC/min with a stability of 0.2uC. The transition melting
temperature, Tm was determined from the first derivative of the
CD versus temperature plot. The stock solution of each new ligand
was prepared in DMSO and diluted in the required buffer prior
to use.
TRAP-LIG Assay [53]
The TRAP assay was performed using a three-step TRAP–LIG
procedure: (i) primer elongation by telomerase and addition of
ligand, (ii) subsequent removal of the ligand, and (iii) PCR
amplification of the products of telomerase elongation.
Step 1. This was carried out by preparing a master mix
containing 0.1 mg of TS forward primer (59-AAT CCG TCG
AGC AGA GTT-39), TRAP buffer (20 mM Tris–HCl, pH 8.3,
68 mM KCl, 1.5 mM MgCl2, 1 mM EGTA, and 0.05% [v/v]
Tween 20), dNTPs (125 mM each), and protein extract (500 ng/
Spacer Length Effect on Telomerase Inhibitors
PLoS ONE | www.plosone.org 9 June 2012 | Volume 7 | Issue 6 | e39467sample) diluted in lysis buffer (10 mM Tris–HCl, pH 7.5, 1 mM
MgCl2, 1 mM EGTA, 0.5% CHAPS, 10% glycerol, 5 mM b-
mercaptoethanol, and 0.1 mM 4-(2-aminoethyl)-benzenesulfonyl
fluoride. The PCR master mix was added to tubes containing
freshly prepared ligand at various concentrations and to a negative
control containing no ligand. The initial elongation step was first
out carried at 30uC for 10 min, then at by 94uC for 5 min and
finally maintaining the mixture at 20uC.
Step 2. To purify the elongated product and to remove the
bound ligands, the QIA quick nucleotide purification kit (Qiagen)
was used according to the manufacturer’s instructions. This kit is
specially designed for the purification of both double- and single-
stranded ODNs from 17 bases in length. It employs a high-salt
buffer to bind the negatively charged ODNs to the positively
charged spin tube membrane through centrifugation so that all
other components, including positively charged and neutral ligand
molecules, are eluted. PCR-grade water was then used (rather
than the manufacturer’s recommendation of an ethanol based
buffer) to wash any impurities away before elution of the DNA
using a low-salt concentration solution. The purified samples were
freeze-dried and then re-dissolved in PCR-grade water at room
temperature prior to the second amplification step.
Step 3. The purified extended samples were then subjected to
PCR amplification. For this, a second PCR master mix was
prepared consisting of 1 mM ACX reverse primer (59-GCG CGG
[CTTACC]3 CTA ACC-39), 0.1 mg TS forward primer (59-AAT
CCG TCG AGC AGA GTT-39), TRAP buffer, 5 mg BSA,
0.5 mM dNTPs, and 2 U Taq polymerase. A 6 ml aliquot of the
master mix was added to the purified telomerase extended samples
and amplified for 30 cycles of: 30 s at 94uC and 30 s at 59uC. The
reaction products were loaded onto a 10% polyacrylamide gel
(19:1) in TBE 0.5 X. Gels were transferred to Whatman 3 mm
paper, dried under vacuum at 80uC, and read using a
phosphorimager 840 (Amersham). Measurements were made in
triplicate with respect to a negative control run using the
equivalent TRAP-PCR conditions but omitting the protein
extract, thus ensuring that the ladders observed were not due to
artefacts of the PCR reaction.
Figure 6. Simulated structures of the dimeric G4DNA-gemini ligand complexes and topology change of the G4DNA. Simulated
structures of (A) D2-dimeric G4DNA complex and (B) D3-dimeric G4DNA complex are shown as a ‘stick’ model. In the case of D2, both
bisbenzimidazole units bind with the grooves of different G4 DNA units. In the case of D3, one bisbenzimidazole stacks on the 59-surface of the G-
quartet plane while the other bisbenzimidazole binds to the groove of the G-quadruplex. K
+ ions present in the central cavity are shown in cyan
colour. Ligand is shown in sticks model colored by atom type (magenta-blue). Hybrid G4DNA is represented as a cartoon form (green-orange). (C and
D) Proposed structures of the dimeric G4DNA formed from longer human telomeric repeats: C) hybrid dimeric G4DNA (dhyq) formed in K
+ solution;
D) parallel dimeric G-quadruplex DNA (dpq) formed in K
+ solution in presence of various ligands (M or Ds).
doi:10.1371/journal.pone.0039467.g006
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HeLa (cervical cancer human transformed cells), A549 (lung
carcinoma human transformed cells) and NIH3T3 (mouse
embryonic fibroblast cells) cells were seeded in 96-well plates
(15.0 610
3/well). Cells were grown for 24 h before treatment to
get .70% confluency and exposed to various concentrations of
ligands in presence of 0.2% FBS. After either 6 h or 48 h
incubation at 37uC in a humidified atmosphere of 5% CO2, old
medium was replaced with the new one containing 10% FBS in
DMEM and cells were further grown for 42 h post treatment.
Then 20 ml of 5 mg/mL methyl thiazolyl tetrazolium (MTT)
reagent was added to 200 ml of the medium present in each well
and cells were further incubated for 4 h. Old medium was
discarded and formazan crystals were dissolved in DMSO and
reading (fluorescence) was taken at 595 nm in the ELISA plate
reader. All ligand doses were parallel tested in triplicate.
Percentage cell viability was calculated by using the formula,
% cell viability = [(FI(595) of treated cells 2 FI(595) of plain
DMSO)/(FI(595) ofuntreated cells2FI(595) ofplainDMSO)]6100.
Long-term Cell Culture Experiments
Long-term cell proliferation experiments were carried out using
HeLa, A549 and NIH3T3 cell lines. Cells were grown in 6 well
tissue culture plate at 5.0 6 10
4 per well and exposed to a sub-
cytotoxic concentration of (4 mM) or an equivalent volume of
0.1% DMSO every 5 days. The cells in control and ligand-
exposed wells were counted and wells were reseeded with half
population of the cells. This process was continued for 15 days.
Cell population vs. time (days) plots were generated.
Selectivity Toward Cancerous Cells
HEK293 (Human embryonic kidney 293) normal cells and
HEK293T ((human embryonic kidney transformed 293) cancer
cells were seeded in 96-well plates (8.0 610
3/well). Experiments
were performed as in the case of short term cell viability assay.
Computational Methods
a) Preparation of dimeric G4DNA. The structures of
different conformations of the basic G-quadruplex units (hybrid-
1 and hybrid-2) were generated using the coordinates of the
reported NMR structures (PDB code 2HY9 and 2JPZ) [10]. To
make the 50-mer dimeric hybrid G4DNA structure, first we
removed one adenine from 39-end of the hybrid-1 structure
(2HY9) and one thymine from the 59-end of the hybrid-2 structure
(2JPZ). Then we joined the 39-end of the hybrid-1G- quadruplex
unit with the 59-end of the hybrid-2 G-quadruplex unit using
ChemCraft software. In each G-quadruplex units, two K
+ ions were
placed between the adjacent G-tetrad planes. In this hybrid-type
model, the monomeric G-quadruplex units were initially disposed
to maximize the stacking interactions between the loop residues.
Molecular dynamics simulations were performed using the ff99SB
force field in the AMBER v9.0 package [57]. The models were
solvated in a 10 A ˚ box of TIP3P water using standard Amber 9.0
leap rules to hydrate the systems and K
+ ions were added for
overall charge neutrality [58]. The systems were heated slowly and
equilibrated for 250 ps with gradual removal of the positional
restraints on DNA following the protocol given below. We (i)
minimized water and metal counter ions with DNA fixed; (ii)
minimized total system; (iii) heated slowly from 0 to 300 K
(100 kcal/mol A ˚ 21) for 50 ps holding DNA fixed; we performed
(iv) 50 ps MD (T=300 K) holding DNA fixed (100 kcal/mol
A ˚ 21), (v) 50 ps MD (T=300 K) holding DNA fixed (50 kcal/mol
A ˚ 21), (vi) 50 ps MD (T=300 K) holding DNA fixed (10 kcal/mol
A ˚ 21) and (vii) 50 ps MD (T=300 K) holding DNA fixed (1 kcal/
mol A ˚ 21). Subsequently, under constant pressure, production run
of MD simulation of 8 ns was performed in an NPT ensemble at 1
atm and 300 K. The output and the trajectory files were saved
every 2 fs for the subsequent analysis, respectively. All trajectory
analysis was done with the Ptraj module in the Amber 9.0 suite
and examined visually using the VMD software package [59].
b) Preparation of ligands and ligand-DNA
complex. These were performed as described earlier [38].
c) Molecular modeling of the ligand-DNA
complex. Partial-atomic charges for the ligand molecules were
derived using the HF/6-31G* basis set followed by RESP
calculation, while force-field parameters were taken from the
generalized Amber force field (GAFF) using ANTECHAMBER
module [60]. In each G-quadruplex units, two K
+ ions were
placed between the adjacent G-tetrad planes. The models were
solvated in a 10 A ˚ box of TIP3P water using standard Amber 9.0
leap rules to hydrate the systems and K
+ ions were added for
overall charge neutrality [57]. The systems were heated slowly and
equilibrated for 250 ps with gradual removal of the positional
restraints on DNA followed by the previous protocol (preparation
of dimeric G4DNA).
Supporting Information
Figure S1 CD spectral titrations of the pre-formed
G4DNA formed with ODN Hum24 and Hum48 in LiCl
solution. CD titrations of the pre-formed G4DNA derived from
the Hum48 [(A) and (B): 4 mM strand concn.] or the Hum24 [(C):
4 mM strand concn.] in LiCl buffer (10 mM Tris-HCl, pH 7.4
having 100 mM LiCl) with indicated ligands and concentrations.
(TIF)
Figure S2 CD spectral titrations of the pre-formed
G4DNA formed with ODN Hum24 in (Na
+ + LiCl)
solution. CD titrations of the pre-formed G4 DNA (2 mM strand
conc.) formed with the Hum24 in (Na
+ + LiCl) solution (10 mM
sodium cacodylate having 100 mM LiCl, Panel A) or in KCl
buffer (10 mM Tris-HCl, pH 7.4 having 100 mM KCl, Panel B)
with D3 at ligand:DNA ratio (r)=5, 10, 15, 20, 25 respectively.
Arrows indicate the increment in the CD intensity.
(TIF)
Figure S3 CD spectral titrations of the pre-formed
G4DNA formed with the Hum48 in (Na
+ + LiCl) solution.
CD titrations of the pre-formed G4DNA (2 mM strand concn.) from
the Hum48 in (Na
+ + LiCl) solution (10 mM sodium cacodylate
having 100 mM LiCl with M (Panel A) and D3 (Panel B) at ligand:
DNA ratio (r)=5, 10, 15, 20, 25 for M and r=5, 10, 15 for D3
respectively. Arrows show the increment in the CD intensity.
(TIF)
Figure S4 Representative CD melting profiles of the
G4DNAs in (Na
+ + LiCl) solution. CD melting at 295 nm of
the pre-formed G4DNA made with the A. Hum24 (4 mM) and B.
Hum48 (2 mM) in (Na
+ + LiCl) solution at 295 nm. G4DNA alone
(Red) or complexed with the indicated ligand (10 equiv.). In case of
M-Hum48,[ M] was 20 equiv.
(TIF)
Figure S5 Representative CD melting profiles of the
G4DNAs in NaCl solution. CD melting at 295 nm of the pre-
formed G4DNA made with A. Hum24 (4 mM) and B. Hum48
(2 mM) in NaCl solution (10 mM Tris-HCl, pH 7.4 having
100 mM NaCl); G4DNA alone (Red) or complexed with each
ligand (10 equiv.). In case of M-Hum48,[ M] was 20 equiv.
(TIF)
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pre-formed G4DNAs in KCl solution. CD melting at
295 nm of the pre-formed G4DNA made with the A. Hum24
(4 mM) and B. Hum48 (2 mM) in KCl solution (10 mM Tris-HCl,
pH 7.4 having 100 mM KCl) at 295 nm; G4DNA alone (Red) or
complexed with each ligand (10 equiv.). In case of M-Hum48,[ M]
was 20 equiv.
(TIF)
Figure S7 CD melting profiles of G4DNA formed in
presence of each ligand in KCl solution. CD melting at
266 nm profiles of G4DNA made with the (A) Hum24 (4 mM) and
(B) Hum48 (2 mM). G4DNA was either formed alone (Red) or
formed in presence of the indicated ligand (10 equiv., first heated
to 95uC for 5 min and then cooled slowly to room temperature) in
KCl solution (10 mM Tris-HCl, pH 7.4 having 100 mM KCl). In
case of M-Hum48,[ M] was 20 equiv. Spectral changes were
monitored at 295 nm for DNA alone and at 266 nm for the DNA-
ligand complexes. (C) Cooling curves of the Hum48 DNA alone
(red, at 295 nm) and with 10 equiv. of D3 (wine, at 266 nm).
(TIF)
Figure S8 UV-visible absorption titration of the gemini
ligands with pre-formed G4DNAs. UV-visible absorption
spectra of three gemini ligands (A). UV-visible absorption titration
of D3 in presence of Hum48 (B) and CT-DNA.
(TIF)
Figure S9 Scatchard plots to determine the binding
affinity constant. Scatchard binding plots (r/Cf vs. r) used to
determine the affinity constants for: A) D1,B )D2 and C) D3 with
the preformed Hum48 G4DNA in 100 mM KCl buffer.
(TIF)
Figure S10 Fluorescence titrations of D3. (A) Fluorescence
titrations of D3 alone with K
+ solution in Tris-HCl buffer, pH 7.4
at 25uC( lex=380 nm). (B) Relative increments in the fluorescence
intensity of each gemini ligand (500 nM) upon addition of the pre-
formed Hum48 G4DNA in KCl buffer (10 mM Tris-HCl having
100 mM KCl and 0.1 mM EDTA, pH 7.4). (C) Representative
emission spectra of titrations with D3. G4DNA formed by the
Hum48 was added from a stock of 4 mM strand concentration to
the solution of the ligand in the cuvette.
(TIF)
Figure S11 Conventional two-step TRAP assay. Telome-
rase inhibitory properties by various bisbenzimidazole ligands.
ConTRAP assay was performed using indicated concentrations
over each lane with M and D1 (left panel); D2 and D3 (middle
panel). Lane 1: (-) ve control, (absence of enzyme and ligand); Lane
2: R = PCR control and Lane 11: (+) ve control (absence of ligand)
in both the cases. Other lanes (lanes 3-10) contain TRAP reaction
mixtures mixed with indicated concentrations (mM) of each ligand.
The rightmost panel shows the inhibition of taq polymerase by the
ligand D3 (Lanes 9 and 10) at 15 and 30 mM concentrations.
(TIF)
Figure S12 Inhibition curves from TRAP-LIG assays for
the complexes D1-3 and M.
(TIF)
Figure S13 Short term cell viability assay. Effect of
different ligands on the cell viability after short-term exposure
(for 6 h and 48 h) of HeLa, A549 and NIH3T3 cells at specified
concentrations as measured from the MTT assay. Each experi-
ment was performed three times and an average at each point is
shown.
(TIF)
Figure S14 Long term cell viability assay. Long-term
exposure of HeLa, A549 and NIH3T3 cells with the indicated
ligands at sub-cytotoxic concentrations. Cells were exposed to
4 mM of each ligand or 0.1% DMSO, respectively. Every 5 days,
the cells in control and ligand-exposed wells were counted and
wells reseeded with cells. Each experiment was performed three
times at each point.
(TIF)
Figure S15 Short term cell viability assay of 5, 10, 15,
20-tetrakis (1-methyl-4-pyridyl)-21H, 23H-porphine)
(H2TMPyP4). Effect of this ligand on the cell viability after
short-term exposure (for 6 h and 48 h) of HeLa, A549 and
NIH3T3 cells at specified concentrations as measured by MTT
assay. Each experiment was performed three times and an average
at each point is shown.
(TIF)
Figure S16 In-silico construction of the dimeric G4DNA.
Dimeric G4DNA is depicted which was formed by joining two
monomeric hybrid structure, hybrid-1 (2HY9) and hybrid-2
(2JPZ). Structure of dimeric G4DNA was constructed using
ChemCraft software.
(TIF)
Figure S17 Simulated structure of dimeric G4DNA.
Simulated structure of dimeric G4DNA (8 ns). K
+ ions present
in the central cavity are shown by cyan colour. Hybrid G4-DNA is
represented as a cartoon form (green-orange).
(TIF)
Figure S18 RMSD values of the ligands. RMSD plots of
dimeric G4DNA and ligand-G4DNA complexes.
(TIF)
Figure S19 Effect of ligands on the cell viability toward
normal and transformed cells at one specific ligand
concentration. Selective % cell viability of normal (HEK293)
against transformed (HEK293T) cells by monomer (M) and the
gemini ligands (D1, D2 and D3) at a particular concentration
(30 mM).
(TIF)
Table S1 Melting temperatures (at 257 nm) of the
Hum24 and Hum48 G4DNAs formed in LiCl solution
and G4DNA-ligand complexes ([ligand]: [DNA] ratio
‘r’ = 10 for M and 5 for the gemini ligands).
(DOCX)
Table S2 Dissociation constants (KD) of the gemini
ligands with the pre-formed Hum48 G4DNA and CT-
DNA determined from UV-vis absorption spectral
titrations.
(DOC)
Table S3 IC50 values (mM, ±5%) of the ligands against
different cell lines after 48 h treatment.
(DOC)
Text S1 Synthesis and characterization of the ligands
used in this study.
(DOC)
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